01012nas a2200385   4500000000100000008004100001260001300042653002300055653003000078653001100108653001800119653001900137653001100156653002600167653001400193653001300207653002300220653001200243653000900255653002500264653003900289653002500328653003300353653001400386653002800400653001500428653003200443653001600475653003000491100001600521245005700537300001100594490000700605022001400612       2004                            d  c2004 Sep10aBacterial Vaccines10aDrug Therapy, Combination10aFemale10aGlobal health10aHIV Infections10aHumans10aImmunotherapy, Active10aIncidence10aLepromin10aLeprostatic Agents10aleprosy10aMale10aMycobacterium leprae10aPeripheral Nervous System Diseases10aPhysical Examination10aPractice Guidelines as Topic10aPregnancy10aPregnancy Complications10aPrevalence10aSensitivity and Specificity10aVaccination10aWorld Health Organization1 aMoschella S00aAn update on the diagnosis and treatment of leprosy.  a417-260 v51  a1097-6787